---
figid: PMC11215075__fphar-15-1406493-g005
figtitle: Ezetimibe, Niemann-Pick C1 like 1 inhibitor, modulates hepatic phospholipid
  metabolism to alleviate fat accumulation
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11215075
filename: fphar-15-1406493-g005.jpg
figlink: /pmc/articles/PMC11215075/figure/F5/
number: F5
caption: 'The proposed hepatic metabolic pathway and altered gene expression by treatment
  with ezetimibe (white arrow) in a rat model of obesity and type 2 diabetes. Abbreviations:
  ACSL1: long-chain acyl-coenzyme A synthetase 1; CCTα: CTP:phosphpocholine cytidylyltransferase
  alpha; DGAT: diacylglycerol acyltransferase; ELOVL5: elongation of very long chain
  fatty acids protein 5; FADS2: fatty acid desaturase 2; FATP5: fatty acid transport
  protein 5; L-FABP: liver fatty acid-binding protein; LPCAT: lysophosphatidylcholine
  acyltransferase; PC: phosphatidylcholine; PE: phosphatidylethanolamine; PEMT: phosphatidylethanolamine
  N-methyl-transferase; PLA2: phospholipase A2; PC-PLC: PC-specific phospholipase
  C.'
papertitle: Ezetimibe, Niemann-Pick C1 like 1 inhibitor, modulates hepatic phospholipid
  metabolism to alleviate fat accumulation.
reftext: Hyekyung Yang, et al. Front Pharmacol. 2024;15:1406493.
year: '2024'
doi: 10.3389/fphar.2024.1406493
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: ezetimibe | hepatic steatosis | phospholipids | metabolomics | lipidomics
automl_pathway: 0.9333313
figid_alias: PMC11215075__F5
figtype: Figure
redirect_from: /figures/PMC11215075__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11215075__fphar-15-1406493-g005.html
  '@type': Dataset
  description: 'The proposed hepatic metabolic pathway and altered gene expression
    by treatment with ezetimibe (white arrow) in a rat model of obesity and type 2
    diabetes. Abbreviations: ACSL1: long-chain acyl-coenzyme A synthetase 1; CCTα:
    CTP:phosphpocholine cytidylyltransferase alpha; DGAT: diacylglycerol acyltransferase;
    ELOVL5: elongation of very long chain fatty acids protein 5; FADS2: fatty acid
    desaturase 2; FATP5: fatty acid transport protein 5; L-FABP: liver fatty acid-binding
    protein; LPCAT: lysophosphatidylcholine acyltransferase; PC: phosphatidylcholine;
    PE: phosphatidylethanolamine; PEMT: phosphatidylethanolamine N-methyl-transferase;
    PLA2: phospholipase A2; PC-PLC: PC-specific phospholipase C.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FADS2
  - RAPSN
  - FABP1
  - SLC27A5
  - ACSL1
  - DGAT1
  - LPCAT3
  - LPCAT1
  - MBOAT2
  - TG
  - PNPLA2
  - PC
  - PLA2G1B
  - PLA2G2A
  - PLA2G6
  - PLA2G3
  - PLA2G5
  - PLA2G7
  - PLA2G10
  - PLA2G12A
  - PLA2G12B
  - PLA2G2C
  - PLA2G2D
  - PLA2G2E
  - PLA2G2F
  - PLA2G4A
  - PLA2G4C
  - PLA2G4D
  - PEMT
  - MUC1
  - LCFA
  - Ezetimibe
  - LCFA-CoA
  - Diacylglycerol
  - VLDL
---
